How do I contact Genentech?
If you are a patient or caregiver, give us a call at (877) 436-3683 or (877) GENENTECH with questions, comments, or suggestions and we'll do our best to help. General information about careers with Genentech.
How do I pay for my Genentech medicine?
If you are concerned about paying for your Genentech medicine, please call our Patient Resource Center at (877) 436-3683. Ready to Enroll? Fill out the Patient Consent Form and send it to Genentech Access Solutions to get started. The form can be submitted in any of these 3 ways: We are here to help.
How do I enroll in Genentech access solutions?
If you are concerned about paying for your Genentech medicine, please call our Patient Resource Center at (877) 436-3683. Ready to Enroll? Fill out the Patient Consent Form and send it to Genentech Access Solutions to get started. The form can be submitted in any of these 3 ways:
Can you get Genentech medicines for free?
Getting Genentech medicines shouldn’t be one of them. The Genentech Patient Foundation gives free Genentech medicine to people who don’t have insurance coverage or who have financial concerns. See if You Qualify Find out if the Genentech Patient Foundation can help you.
See more
What is the Genentech Patient Foundation?
The Genentech Patient Foundation gives free Genentech medicine to people who don't have insurance coverage or who have financial concerns.
What is Genentech Access Solutions?
Access Solutions is a program from Genentech and is committed to helping you understand your insurance coverage and options that might be able to help you pay for your Genentech medicine. Call (866) 422-2377 or visit Genentech-Access.com for more information.
What drugs does Genentech make?
Our Medicines & ProductsMedicines.Actemra® (TOCILIZUMAB [authorized for Emergency Use])Actemra® (tocilizumab)Activase® (alteplase)Alecensa® (alectinib)Avastin® (bevacizumab)Boniva Tablets® (ibandronate sodium)Cathflo Activase® (alteplase)More items...
What is Ophthalmology access solutions?
We focus on access so you can focus on health Genentech Ophthalmology Access Solutions is a program that helps people who are taking a Genentech medicine. Your health insurance plan and the cost of your medicine might keep you from getting your prescribed treatment.
Who makes Valganciclovir?
Genentech: Valcyte® (valganciclovir hydrochloride) - Information for Patients.
What is Genentech best known for?
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Who is Genentech owned by?
As of July 2021, Genentech employed 13,539 people....Genentech.TypePrivate ( Independent subsidiary)Number of employees13,539 (July 2021)ParentHoffmann-La RocheWebsitewww.gene.com7 more rows
Who bought Genentech?
Roche Holding'sRoche Holding's agreement on Thursday to acquire full ownership of Genentech for $46.8 billion is the third big drug industry merger this year.
How many drugs does Genentech have?
Genentech, Inc. manufactures, markets and/or distributes more than 47 drugs in the United States.
What drugs does Roche make?
All. Actemra/RoActemra. Alecensa. ... Anaemia. Mircera. NeoRecormon.Cancer (blood tumours) Gazyva/Gazyvaro. MabThera / Rituxan. ... Cancer (blood cancers) Alecensa. Avastin. ... Dermatology. Roaccutane/Accutane.Haemophilia. Hemlibra.Infectious Diseases. Actemra/RoActemra. Copegus. ... Inflammatory & Autoimmune Diseases. Actemra/RoActemra. CellCept.More items...
What MS drugs does Genentech make?
About OCREVUS OCREVUS is approved by the FDA to treat relapsing or primary progressive forms of multiple sclerosis (MS).
What oncology drugs does Genentech make?
Oral ProductsALECENSA® (alectinib)COTELLIC® (cobimetinib)Erivedge® (vismodegib)GAVRETO® (pralsetinib)ROZLYTREK® (entrectinib)VENCLEXTA® (venetoclax)XELODA® (capecitabine)ZELBORAF® (vemurafenib)
What is the number to call Genentech?from genentech-access.com
Getting your prescribed medicines should not be one of them. If you are concerned about paying for your Genentech medicine, please call our Patient Resource Center at (877) 436-3683.
How to contact Genentech about compassionate use?from gene.com
If you are seeking information about access to one of Genentech's investigational medicines, please call Genentech's Clinical Trial Information Support Line at (888) 662-6728 or Genentech's Compassionate Use Information Line at (844) ...
What is GSF patient library?from geneticsupportfoundation.org
GSF has a Patient Library that provides more background information on a variety of topics in genetics, including a genetics overview (Genetics 101), Genetics & Pregnancy, and Genetics & Cancer, among others. Learn more.
Does Genentech support evrysdi?from gene.com
Please Note: At this time, Genentech supports Evrysdi, Nutropin, Cellcept, Valcyte, and Fuzeon through a separate process.
Who owns Genentech?from en.wikipedia.org
In 1990 F. Hoffmann-La Roche AG acquired a majority stake in Genentech.
What is Genentech's research?from en.wikipedia.org
Genentech was a pioneering research-driven biotechnology company that has continued to conduct R&D internally as well as through collaborations. Genentech's research collaborations include: In 2008 Genentech entered into a collaboration with Roche and its subsidiary GlycArt to develop obinutuzumab.
How much did Genentech pay for patent litigation?from en.wikipedia.org
In November 1999, Genentech agreed to pay the University of California, San Francisco $200 million to settle a nine-year-old patent dispute. In 1990, UCSF sued Genentech for $400 million in compensation for alleged theft of technology developed at the university and covered by a 1982 patent.
What documentary was Genentech in?from en.wikipedia.org
Genentech was featured in the documentary film Something Ventured which premiered in 2011.
What is Tecentriq used for?from en.wikipedia.org
2016: Tecentriq (atezolizumab): First-in-class anti-PD-L1 antibody for the treatment of advanced bladder cancer or metastatic non-small cell lung cancer (NSCLC), both after failure of platinum-based chemotherapy. Tecentriq was granted accelerated approval for its advanced bladder cancer indication due to promising phase II results.
When did Genentech join Roche?from gene.com
Genentech became a member of the Roche Group in March of 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States.
Is Genentech a top employer?from en.wikipedia.org
The company participates in various policy and civic leadership groups, such as TechNet, and sponsors independent third-party research and publications, such as the journal Nature. Genentech was named Top Employer by Science Magazine on October 7, 2010, where it has been recognized for nine consecutive years.
Who provides Genentech medicine?
The Genentech Patient Foundation provides free Genentech medicine to people who don't have insurance coverage or who have financial concerns and to people who meet certain income criteria.*
What is Erivedge Access Solutions?
For eligible patients with commercial or public health insurance, Erivedge Access Solutions offers referrals to independent co-pay assistance foundations.†
Does Erivedge refer to Genentech?
If eligible commercially insured patients need assistance with their out-of-pocket costs, Erivedge Access Solutions can refer them to the Genentech Oncology Co-pay Assistance Program.*
How to report side effects of Genentech?
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555. Please see full Prescribing Information , including Boxed WARNINGS and Medication Guide, for additional Important Safety Information.
How to contact mycophenolateREMS?
by phone at 1-800-617-8191 or. by visiting the Risk Evaluation and Mitigation Strategy (REMS) website at www.mycophenolateREMS.com. The purpose of this registry is to gather information about the health of you and your baby. Increased risk of getting certain cancers.
How long after stopping CellCept can you donate blood?
You should not donate blood while taking CellCept and for at least 6 weeks after stopping CellCept.
Does cellcept cause side effects?
CELLCEPT CAN CAUSE SERIOUS SIDE EFFECTS, INCLUDING: Increased risk of loss of a pregnancy (miscarriage) and higher risk of birth defects. Females who take CellCept during pregnancy have a higher risk of miscarriage during the first 3 months (first trimester), and a higher risk that their baby will be born with birth defects.
How to report side effects of Genentech?from actemra.com
You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555. Please see full Prescribing Information and the Medication Guide, including Serious Side Effects, for more Important Safety Information.
How to contact Genentech about Actemra?from gene.com
Medicine Information Support. Ask about possible side effects and any other medical questions related to your prescribed Genentech medicine. Call us at (800) 821-8590, Monday-Friday, 5am-5pm PT. Chat with us using our live chat feature, Monday-Friday, 5am-5pm PT.
What is Genentech focused on?from gene.com
Genentech has always focused on developing breakthrough medicines for serious illnesses. We believe every person should get the Genentech medicine they need, and we offer programs to help make this happen.
Can Genentech medicines be used for serious illness?from gene.com
Living with a serious illness can come with many challenges. Getting Genentech medicines shouldn’t be one of them. The Genentech Patient Foundation gives free Genentech medicine to people who don’t have insurance coverage or who have financial concerns. See if You Qualify.
Eligibility
Genentech Access to Care Foundation (Pulmozyme), a patient assistance program provided by Genentech, Inc., offers Pulmozyme at no cost for one use to those who are eligible for the program. Eligibility is based off of the following requirements:
Other Tips
If you have any questions please call the Genentech, Inc. program directly.
